Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by CHARLES CLEELAND and XIN SHELLEY WANG.
CHARLES CLEELAND
Connection Strength
9.504
XIN SHELLEY WANG
  1. Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial. Support Care Cancer. 2021 Oct; 29(10):6099-6107.
    View in: PubMed
    Score: 0.785
  2. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014 Feb 01; 120(3):425-32.
    View in: PubMed
    Score: 0.478
  3. Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation. Clin Cancer Res. 2014 Mar 01; 20(5):1366-74.
    View in: PubMed
    Score: 0.476
  4. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun. 2012 Jul; 26(5):699-705.
    View in: PubMed
    Score: 0.414
  5. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer. 2010 Apr 15; 116(8):2053-63.
    View in: PubMed
    Score: 0.367
  6. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer. 2010 Jan 01; 116(1):137-45.
    View in: PubMed
    Score: 0.360
  7. Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol. 2006 Sep 20; 24(27):4485-91.
    View in: PubMed
    Score: 0.287
  8. Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients. J Pain Symptom Manage. 2006 Jun; 31(6):542-52.
    View in: PubMed
    Score: 0.281
  9. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer. 2004 Oct 15; 101(8):1890-901.
    View in: PubMed
    Score: 0.251
  10. Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C). J Pain Symptom Manage. 2004 Apr; 27(4):322-32.
    View in: PubMed
    Score: 0.242
  11. End-of-life care in urban areas of China: a survey of 60 oncology clinicians. J Pain Symptom Manage. 2004 Feb; 27(2):125-32.
    View in: PubMed
    Score: 0.239
  12. Pediatric cancer pain management practices and attitudes in China. J Pain Symptom Manage. 2003 Aug; 26(2):748-59.
    View in: PubMed
    Score: 0.231
  13. Patient-reported symptoms at discharge and risk of complications after gynecologic surgery. Int J Gynecol Cancer. 2023 02 06; 33(2):271-277.
    View in: PubMed
    Score: 0.223
  14. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol. 2002 Mar 01; 20(5):1319-28.
    View in: PubMed
    Score: 0.209
  15. Fatigue during preoperative chemoradiation for resectable rectal cancer. Cancer. 2001 Sep 15; 92(6 Suppl):1725-32.
    View in: PubMed
    Score: 0.203
  16. Development of a patient-reported outcome tool for assessing symptom burden during perioperative care in liver surgery: The MDASI-PeriOp-Hep. Eur J Oncol Nurs. 2021 Jun; 52:101959.
    View in: PubMed
    Score: 0.197
  17. Assessment of physical function by subjective and objective methods in patients undergoing open gynecologic surgery. Gynecol Oncol. 2021 04; 161(1):83-88.
    View in: PubMed
    Score: 0.194
  18. Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial. Int J Radiat Oncol Biol Phys. 2020 01 01; 106(1):100-107.
    View in: PubMed
    Score: 0.177
  19. Minocycline for Symptom Reduction During Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial. J Pain Symptom Manage. 2019 10; 58(4):662-671.
    View in: PubMed
    Score: 0.174
  20. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN). Gynecol Oncol. 2019 03; 152(3):492-500.
    View in: PubMed
    Score: 0.170
  21. The Chinese version of the Brief Pain Inventory (BPI-C): its development and use in a study of cancer pain. Pain. 1996 Oct; 67(2-3):407-16.
    View in: PubMed
    Score: 0.144
  22. Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy. J Pain Symptom Manage. 2016 05; 51(5):832-8.
    View in: PubMed
    Score: 0.138
  23. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review. Support Care Cancer. 2015 Feb; 23(2):513-24.
    View in: PubMed
    Score: 0.125
  24. Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors. Cancer. 2014 Feb 01; 120(3):442-50.
    View in: PubMed
    Score: 0.117
  25. Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res. 2013 Nov; 22(9):2331-9.
    View in: PubMed
    Score: 0.112
  26. Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force. Cancer. 2013 Jan 15; 119(2):411-20.
    View in: PubMed
    Score: 0.108
  27. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol. 2012 Apr; 13(4):395-402.
    View in: PubMed
    Score: 0.104
  28. Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. J Clin Oncol. 2011 Jul 20; 29(21):2859-65.
    View in: PubMed
    Score: 0.100
  29. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist. 2011; 16(2):217-27.
    View in: PubMed
    Score: 0.097
  30. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol. 2011 Mar 10; 29(8):994-1000.
    View in: PubMed
    Score: 0.097
  31. Assessment of fatigue in cancer patients and community dwellers: validation study of the Filipino version of the brief fatigue inventory. Oncology. 2010; 79(1-2):112-7.
    View in: PubMed
    Score: 0.096
  32. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer. J Pain Symptom Manage. 2010 Jul; 40(1):75-86.
    View in: PubMed
    Score: 0.093
  33. Does recall period have an effect on cancer patients' ratings of the severity of multiple symptoms? J Pain Symptom Manage. 2010 Aug; 40(2):191-9.
    View in: PubMed
    Score: 0.093
  34. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun. 2010 Aug; 24(6):968-74.
    View in: PubMed
    Score: 0.092
  35. Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst. 2010 May 19; 102(10):732-8.
    View in: PubMed
    Score: 0.091
  36. Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer. 2008 Oct 15; 113(8):2102-9.
    View in: PubMed
    Score: 0.083
  37. Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage. 2009 Feb; 37(2):168-74.
    View in: PubMed
    Score: 0.082
  38. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1355-61.
    View in: PubMed
    Score: 0.080
  39. Fatigue in the general Korean population: application and normative data of the Brief Fatigue Inventory. J Pain Symptom Manage. 2008 Sep; 36(3):259-67.
    View in: PubMed
    Score: 0.080
  40. Russian Brief Pain Inventory: validation and application in cancer pain. J Pain Symptom Manage. 2008 Jan; 35(1):95-102.
    View in: PubMed
    Score: 0.078
  41. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007 Oct; 29(10):923-31.
    View in: PubMed
    Score: 0.077
  42. Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant. 2007 Jun; 39(12):759-66.
    View in: PubMed
    Score: 0.075
  43. Symptoms in the lives of terminal cancer patients: which is the most important? Oncology. 2006; 71(1-2):69-76.
    View in: PubMed
    Score: 0.074
  44. Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients. J Pain Symptom Manage. 2007 Feb; 33(2):180-8.
    View in: PubMed
    Score: 0.074
  45. Clinicians' practice and attitudes toward cancer pain management in Korea. Support Care Cancer. 2007 May; 15(5):463-9.
    View in: PubMed
    Score: 0.072
  46. Validation of the Taiwanese version of the Brief Fatigue Inventory. J Pain Symptom Manage. 2006 Jul; 32(1):52-9.
    View in: PubMed
    Score: 0.071
  47. The association between symptom burdens and utility in Chinese cancer patients. Qual Life Res. 2006 Oct; 15(8):1427-38.
    View in: PubMed
    Score: 0.070
  48. Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2006 Apr; 31(4):345-52.
    View in: PubMed
    Score: 0.069
  49. Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2005 Nov; 30(5):443-53.
    View in: PubMed
    Score: 0.067
  50. Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage. 2005 Feb; 29(2):165-72.
    View in: PubMed
    Score: 0.064
  51. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation. 2004; 11(5):279-92.
    View in: PubMed
    Score: 0.059
  52. Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology. 2004; 66(6):439-44.
    View in: PubMed
    Score: 0.059
  53. Pain and fatigue in community-dwelling adults. Pain Med. 2003 Sep; 4(3):231-7.
    View in: PubMed
    Score: 0.058
  54. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer. 2003 Jun 01; 97(11):2919-25.
    View in: PubMed
    Score: 0.057
  55. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage. 2003 Apr; 25(4):307-18.
    View in: PubMed
    Score: 0.056
  56. Special aspects of cancer pain management in a Chinese general hospital. Eur J Pain. 2001; 5 Suppl A:15-20.
    View in: PubMed
    Score: 0.048
  57. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000 Oct 01; 89(7):1634-46.
    View in: PubMed
    Score: 0.047
  58. The effects of pain severity on health-related quality of life: a study of Chinese cancer patients. Cancer. 1999 Nov 01; 86(9):1848-55.
    View in: PubMed
    Score: 0.044
  59. A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy. Cancer Res. 2014 Nov 01; 74(21):5955-62.
    View in: PubMed
    Score: 0.031
  60. Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density. J Clin Oncol. 2014 Oct 01; 32(28):3156-62.
    View in: PubMed
    Score: 0.031
  61. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014 Jul 01; 120(13):1975-84.
    View in: PubMed
    Score: 0.030
  62. Screening for depressed mood in patients with cancer using the MD Anderson Symptom Inventory: investigation of a practical approach for the oncologist. J Oncol Pract. 2014 Mar; 10(2):e95-102.
    View in: PubMed
    Score: 0.029
  63. Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Cancer. 2013 Dec 01; 119(23):4188-95.
    View in: PubMed
    Score: 0.029
  64. Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy. Cancer Chemother Pharmacol. 2013 Jun; 71(6):1531-40.
    View in: PubMed
    Score: 0.028
  65. Validation of the M. D. Anderson Symptom Inventory multiple myeloma module. J Hematol Oncol. 2013 Feb 05; 6:13.
    View in: PubMed
    Score: 0.028
  66. Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer. Qual Life Res. 2013 Oct; 22(8):2143-50.
    View in: PubMed
    Score: 0.028
  67. Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy. Clin Cancer Res. 2012 Jun 01; 18(11):3180-7.
    View in: PubMed
    Score: 0.026
  68. Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2009 Nov 01; 75(3):775-81.
    View in: PubMed
    Score: 0.021
  69. Assessing cancer symptoms in adolescents with cancer using the Taiwanese version of the M. D. Anderson Symptom Inventory. Cancer Nurs. 2008 May-Jun; 31(3):E9-16.
    View in: PubMed
    Score: 0.020
  70. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. 2007 Aug; 7(2):151-60.
    View in: PubMed
    Score: 0.019
  71. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer. 2007 Jul; 15(7):891-6.
    View in: PubMed
    Score: 0.019
  72. Adequacy of cancer pain management in a Japanese Cancer Hospital. Jpn J Clin Oncol. 2004 Jan; 34(1):37-42.
    View in: PubMed
    Score: 0.015
  73. Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage. 2003 Dec; 26(6):1093-104.
    View in: PubMed
    Score: 0.015
  74. Validation study of the Japanese version of the brief fatigue inventory. J Pain Symptom Manage. 2003 Feb; 25(2):106-17.
    View in: PubMed
    Score: 0.014
  75. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999 Mar 01; 85(5):1186-96.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.